JESSICA BALVITSCH: Open Payments
NPI 1043316524 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 11 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $256 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 1 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: ARISTADA, FANAPT, INGREZZA, CAPLYTA, UZEDY, ZURZUVAE, NUPLAZID, REXULTI.
Industry payments across ND — which companies pay providers there.
